sparfloxacin has been researched along with Maxillary Sinusitis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Adelglass, J; Henry, DC; Jablonski, CK; Moller, DJ; Scheld, WM; Talbot, GH; Zhang, H | 1 |
| Buffington, D; Garrison, N; Granito, K; Spector, S; Stafford, C; Talbot, GH; Zhang, H | 1 |
2 trial(s) available for sparfloxacin and Maxillary Sinusitis
| Article | Year |
|---|---|
Comparison of sparfloxacin and clarithromycin in the treatment of acute bacterial maxillary sinusitis. Sparfloxacin Multicenter AMS Study Group.
Topics: Acute Disease; Adult; Anti-Bacterial Agents; Anti-Infective Agents; Bacterial Infections; Clarithromycin; Double-Blind Method; Drug Administration Schedule; Female; Fluoroquinolones; Humans; Male; Maxillary Sinusitis | 1999 |
Sparfloxacin for the treatment of acute bacterial maxillary sinusitis documented by sinus puncture.
Topics: Acute Disease; Anti-Infective Agents; Bacterial Infections; Fluoroquinolones; Follow-Up Studies; Humans; Maxillary Sinusitis; Punctures | 2000 |